INTRODUCTION
============

Shoulder surgery is often associated with postoperative pain, and approximately 30-70% of patients who undergo shoulder surgery have severe postoperative pain \[[@R1]\]. This postoperative pain has to be controlled to enable the patients to participate in early rehabilitation exercise \[[@R2]\]. Boss *et al*. reported that severe postoperative pain, particularly within the first postoperative 48 hours, is frequently observed after rotator cuff repair \[[@R3]\]. However, postoperative pain cannot be easily controlled. A variety of techniques are currently used to reduce postoperative pain, such as intra-articular morphine \[[@R4]-[@R7]\], regional nerve blocks \[[@R8]\], patient-controlled analgesia \[[@R9]\], and continuous-flow cold therapy \[[@R10]-[@R12]\]. A recent study showed that brachial plexus block is one of the most effective treatment modalities during arthroscopic shoulder surgery \[[@R13]\]. However, several side effects have been reported, including failure of the nerve block, phrenic nerve palsy, and rebounding pain.

Pain is a sensation associated with subjective factors and it is therefore difficult to measure and assess \[[@R14]\]. Accordingly, subjective assessment methods such as the visual analogue scale (VAS) or face pain rating scale have been mainly used \[[@R15],[@R16]\]. These systems have some drawbacks; for example, the VAS has an upper boundary and the face pain rating scale cannot assess continuous variables. In recent years, the PainVision™ system (PS-2100, Nipro Corporation, Osaka, Japan), a quantitative assessment device that functions by substituting pain with different sensory stimuli, has been developed and used mainly in the field of anesthesiology and in pain clinics \[[@R17],[@R18]\].

In the present study, we used the PainVision™ system to evaluate the effect of plexus brachialis block on postoperative pain after arthroscopic rotator cuff repair. The hypothesis of this study is that the PainVision™ system is more accurate than the VAS to evaluate postoperative pain after arthroscopic rotator cuff repair.

PATIENTS AND METHODS
====================

We performed the case-control study including a total of 55 patients recruited from July 1, 2010, to December 31, 2012. The inclusion criteria were as follows: (1) patients had rotator cuff tear with no other concomitant injury of the involved shoulder, and (2) patients were scheduled to undergo primary arthroscopic rotator cuff repair. Exclusionary criteria were known allergy or hypersensitivity to local anesthetic medications; history of infection at the surgical site within 1 year; history of substance abuse; history of chronic pain syndrome or neuropathy; history of mental illness; use of antidepressants; need for concomitant procedures such as an acromioclavicular joint resection, labral repair, biceps tenodesis, or regional block perioperatively; history of a previous rotator cuff repair; and need for open rotator cuff repair. The IRB protocols were approved by the Institutional Review Board of our institution. All patients received general anesthesia. Induction was achieved with propofol 1.5−2 mg/kg, rocuronium 0.6−1.0 mg/kg, and fentanyl 1−2 μg/kg, and general anesthesia was maintained with 2−5% sevoflurane and 66% N~2~O in oxygen. For the first 26 cases, no plexus brachialis block was performed (control group; without plexus brachialis block), and for the next 29 cases, the plexus brachialis block was performed by the anesthesiologist under ultrasonographic guidance using 5−10 mL of ropivacaine before surgery (block group; receiving plexus brachialis block). All surgeries were performed by the same senior author. Arthroscopic rotator cuff repair with subacromial decompression was performed using standard techniques. A single row technique was used for small tears, and a suture bridge technique was used for medium to large-sized and massive tears. Concomitant arthroscopic procedures were recorded, and the tear size, operative time, and number of anchors were also recorded. The tear size in complete tears was classified according to the Cofield classification \[[@R19]\]. After closure, patients received a bolus injection of 20 mL of 0.375% ropivacaine into the gleno-humeral joint. All patients were provided with a sling bandage appropriate for the surgery performed.

The postoperative resting pain was assessed using the VAS at 8, 16, 24, and 48 hours after surgery. Assessment using the PainVision™ system was performed at 16 hours after surgery. First, sensors transmitting an electric current were attached to the medial forearm contralateral to the operated limb. The current perception threshold, which indicated the pain threshold of each subject, was measured twice, and the mean value was recorded. Second, the pain-compatible electrical current was measured as follows: a gradually increasing pulsed current was applied to the contralateral medial forearm. When the pain caused by the arthroscopic shoulder surgery and the magnitude of electric stimulation were believed to be equal, the current was defined as the pain-compatible electrical current (Fig. **[1](#F1){ref-type="fig"}**). The pain-compatible electrical current was measured twice, and the mean value was recorded. On the basis of these measurements, pain intensity was calculated using the following equation:

The current perception threshold and the pain-compatible electrical current were measured. On the basis of these measurements, pain intensity was calculated using the following equation: Pain intensity = 100 × (pain-compatible electrical current − current perception threshold)/current perception threshold.

Pain intensity = 100 × (pain-compatible electrical current − current perception threshold)/current perception threshold.

If the patients requested further pain control, non-steroidal anti-inflammatory agents (NSAIDs), diclofenac sodium (50 mg) was administered. Abnormal symptoms such as tingling, perioral numbness, hearing disturbances, visual disturbances, dysarthria, dizziness, nausea, and vomiting were recorded during the first 48 hours after surgery. Shoulder shrugging and active motions of the fingers, wrist, and elbow were permitted immediately after the procedure.

The results were statistically analyzed using a software package (Statview 5.0; Abacus Concepts Inc., Berkeley, CA). Data are expressed as the mean ± standard deviation. Statistical analyses were performed with the Student's t-test. Comparison of gender between the 2 groups was performed with the chi-square analysis. The ANOVA test was used to compare the size of tears between the 2 groups. The relationship between the pain intensity and VAS was statistically analyzed using Pearson's correlation coefficient. P \< 0.05 was used to denote statistical significance.

RESULTS
=======

In the backgrounds of 55 patients enrolled in the study, there were no significant differences between the 2 groups regarding age, gender, type of tear, operative time, or number of anchors used for rotator cuff repair (Table **[1](#T1){ref-type="table"}**).

The mean VAS values at 4 and 8 hours postoperatively were significantly lower in the block group than in the control group. However, no differences in the VAS values at 16 and 24 hours were detected between the 2 groups (4 hours: P \< 0.01, 16 hours: P = N.S., 24 hours: P = N.S.) (Fig. **[2](#F2){ref-type="fig"}**).

The pain intensity at 16 hours after surgery, as assessed by PainVision™, was significantly lower in the block group than in the control group (P \< 0.05) (Fig. **[3](#F3){ref-type="fig"}**). The pain intensity and VAS at 16 hours after surgery were highly correlated in both block and control groups (Pearson's correlation coefficient r = 0.59, P = 0.006 in the block group and r = 0.62, P = 0.003 in the control group) (Fig. **[4](#F4){ref-type="fig"}**). The effect size of the assessment by PainVision™ was bigger than that of VAS (r=0.31 in VAS and 0.51 in Pain vision).

To support the results of VAS and the pain intensity assessed by PainVision™, the NSAIDs usage after surgery was checked. The total amount of the NSAIDs used during postoperative hours 0−16 was significantly greater in the control group than in the block group. (P \< 0.05) (Fig. **[5](#F5){ref-type="fig"}**).

No severe complications such as infection, nerve injury, or pneumothorax were observed.

DISCUSSION
==========

Shoulder surgery frequently results in severe postoperative pain, and the underlying mechanism has been characterized as follows: the nerves located in the shoulder joint can be damaged during surgery, exerting pressure on nociceptors associated with intra-operative damage; reflective muscle contractions are induced in many muscles connecting the vertebral spine and the upper extremities adjacent to these joints \[[@R20]\]. Therefore, the preemptive and intraoperative analgesia provided by local infiltration, intravenous regional anesthesia, intra-articular anesthesia, neuraxial block, peripheral nerve block, and continuous infusions should be considered \[[@R7]\]. An increase in postoperative pain is correlated with a decrease in patient's quality of recovery in the immediate postoperative period \[[@R21]\]. It was reported that postoperative pain control is essential following surgery so that patients can participate in early rehabilitation exercise \[[@R2]\]. Especially, the first 24 hours after surgery are important for the control of pain after arthroscopic shoulder surgery \[[@R20]\].

Currently, subjective methods such as the VAS are frequently used as pain assessment methods \[[@R14]-[@R16]\]. In these methods, the intensity of pain is determined by comparing the reported pain level with a "pain of maximum intensity" value. However, quantitative data comparisons are difficult with these subjective methods, as the sensitivity to pain varies greatly among individuals. A quantitative analysis device for perception and pain called "PainVision™" was recently developed and has been used in the field of pain and anesthesiology \[[@R7],[@R17]\]. This system is based on the provision of alternative painless sensory stimulation equivalent to pain (through the stimulation of sensory nerve fibers Aβ and Aδ) and the measurement of the intensity of the stimulation. Because individual pain thresholds are evaluated first for accurate subsequent measurement with the device, pain intensity can be quantitatively compared among patients. Therefore, this device enables a more objective evaluation when compared with other commonly used methods. The results of the present study showed that, in the correlation analysis, the pain intensity and VAS at 16 hours after surgery were highly correlated. Therefore, the PainVision™ system could be considered as efficient as the VAS for the assessment of postoperative pain. The results of PainVision™ assessment showed that the pain intensity at 16 hours after surgery was significantly lower in the block group than in the control group. On the other hand, the mean VAS at 16 hours postoperatively showed a lower score in the block group than in the control group, although the difference between the 2 groups did not reach statistical significance. To compare the strength of relationship between VAS and Pain vision system, we calculated the effect size. The results demonstrated that the effect size of the assessment by PainVision™ was bigger than that of VAS. As an effect size is a measure of the strength of relationship and relates to the power of a study, this result indicated that the PainVision™ system could be more accurate in the assessment of postoperative pain compared with VAS. Our result of NSAIDs usage indicated that the patients felt more pain during postoperative hours 0−16, which would support the validity in the results assessed by PainVision™. Matsumura *et al*. also reported that the PainVision™ system is more sensitive than conventional assessment methods such as the VAS because it enables a highly reproducible quantification and comparison of pain intensity independent of individual pain thresholds \[[@R17]\]. Similarly, a discrepancy of the statistical results at 16 hours postoperatively between the VAS and PainVision™ systems might be associated with differences in pain sensitivity. From these results in this paper, it could be possible that the PainVision™ system would make us evaluate the postoperative pain more objectively and accuracy.

The interscalene brachial plexus block is the most frequently used pain relief technique in arthroscopic shoulder surgery \[[@R22]-[@R24]\]. Singelyn *et al*. reported that this block was the most efficient analgesic technique after arthroscopic acromioplasty \[[@R24]\]. Therefore, in our institute, a single-dose interscalene block is performed during arthroscopic shoulder surgery. The results of our study indicated that a single-dose interscalene block could significantly reduce postoperative pain for 8−16 hours after surgery and decrease the total amount of NSAIDs used 16 hours postoperatively. Therefore, the plexus brachialis blockade is effective to reduce postoperative pain after arthroscopic rotator cuff repair. Additionally, a recent study reported that single-dose interscalene block with continuous intralesional infusion of ropivacaine provides effective pain control \[[@R25]\]. On the other hand, Klein *et al*. reported that continuous intra-articular infusion of ropivacaine combined with single-dose interscalene block provides better pain relief than interscalene block alone \[[@R26]\]. As a next step, we plan to compare the effectiveness of single-dose interscalene block with that of single-dose interscalene block combined with continuous intra-articular infusion of ropivacaine.

The present study has some limitations, such as the small number of subjects and the inclusion of a single institution. However, one of the advantages is that all the surgeries were performed by a single surgeon. Second, the patients did not use narcotics as an analgesic because of the protocol of this study, which was different from usual situation. Third, we assessed the pain intensity assessed by PainVision™ in just one time 16 hours after surgery. The further examination will be needed.

CONCLUSION
==========

The results of our study indicated that the PainVision™ system could be useful for the evaluation of postoperative pain because it enables the quantification and comparison of pain intensity independent of individual pain thresholds.
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NSAIDs
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###### 

Comparison of characteristics and demographics between 2 groups.

  ---------------------------------------------------------------------
                                Block Group\   Control Group\   P\
                                (n = 26)       (n =29)          Value
  ----------------------------- -------------- ---------------- -------
  Age \[mean (range)\] (year)   67.9 (48-83)   66.2 (33-83)     0.48

  Gender ( male/female)         19/7           20/9             0.86

  Type of tear                  \-             \-               0.65

  partial                       4              6                \-

  small                         2              2                \-

  medium                        7              6                \-

  large                         4              5                \-

  masstve                       9              10               \-

  Operative time\               154.3±38.8     147.0±44.2       0.54
  (mean± SD) (min)                                              

  Number of anchor\             3.8±0.2        3.7±0.3          0.82
  (mean± SD)                                                    
  ---------------------------------------------------------------------
